Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Eberhardt

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1996
Functional and structural features of plasma platelet-activating factor acetylhydrolaseL W Tjoelker, C Eberhardt, C Wilder, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
Journal of the American College of Radiology : JACR|February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillanceSteven C Eberhardt, Scott Carter, David D Casalino, et al.
The Journal of Urology|June 21, 2016
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SARAndrew B Rosenkrantz, Sadhna Verma, Peter Choyke, et al.
Nature|April 4, 1996
Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleP Carmeliet, V Ferreira, G Breier, et al.
Abdominal Radiology (New York)|September 28, 2016
Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsySadhna Verma, Andrew B Rosenkrantz, Peter Choyke, et al.
Nature|April 6, 1995
Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseL W Tjoelker, C Wilder, C Eberhardt, et al.
Journal of the American College of Radiology : JACR|August 17, 2016
ACR Appropriateness Criteria Staging of Testicular MalignancyJoseph H Yacoub, Aytekin Oto, Brian C Allen, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Hematospermia, Keyanoosh Hosseinzadeh, Aytekin Oto, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Prostate Cancer-Pretreatment Detection, Surveillance, and Staging, Fergus V Coakley, Aytekin Oto, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Advances in Experimental Medicine and Biology|January 1, 1996
Functional and structural features of plasma platelet-activating factor acetylhydrolaseL W Tjoelker, C Eberhardt, C Wilder, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
Journal of the American College of Radiology : JACR|February 5, 2013
ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillanceSteven C Eberhardt, Scott Carter, David D Casalino, et al.
The Journal of Urology|June 21, 2016
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SARAndrew B Rosenkrantz, Sadhna Verma, Peter Choyke, et al.
Nature|April 4, 1996
Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleP Carmeliet, V Ferreira, G Breier, et al.
Abdominal Radiology (New York)|September 28, 2016
Commentary regarding a recent collaborative consensus statement addressing prostate MRI and MRI-targeted biopsy in patients with a prior negative prostate biopsySadhna Verma, Andrew B Rosenkrantz, Peter Choyke, et al.
Nature|April 6, 1995
Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseL W Tjoelker, C Wilder, C Eberhardt, et al.
Journal of the American College of Radiology : JACR|August 17, 2016
ACR Appropriateness Criteria Staging of Testicular MalignancyJoseph H Yacoub, Aytekin Oto, Brian C Allen, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Hematospermia, Keyanoosh Hosseinzadeh, Aytekin Oto, et al.
Journal of the American College of Radiology : JACR|May 6, 2017
ACR Appropriateness Criteria<sup>®</sup> Prostate Cancer-Pretreatment Detection, Surveillance, and Staging, Fergus V Coakley, Aytekin Oto, et al.
Pageof 10